Recent advances in cardiovascular imaging : part 2 by Borg, Alexander
cardiovascular imaging as a subspecialty field within the mother specialties of Cardiology and Radiology has become increasingly popular over the last decade. The main reasons 
behind this are (a) the rapidly expanding repertoire of imaging 
modalities, as seen with the advent of cardiovascular magnetic 
resonance imaging (CMR) and cardiac computed tomography 
(CCT), (b) the technological improvements which greatly 
improve the reliability of these examinations, exemplified by 
rapid tomographic scanning, real time 3D echocardiography 
and the introduction of ultrasonic contrast agents, and (c) 
the potential to reduce the need for invasive investigations, 
represented mainly by the wide choice of functional imaging 
modalities to detect cardiac ischaemia, and the tissue 
characterisation potential of CMR.
In this review, I will summarise the technological advances 
in cardiovascular imaging, highlighting their important clinical 
role. The first part of this series will deal with echocardiography, 
while the second part will address the role of cardiac 
tomographic imaging (Computed tomography and Magnetic 
Resonance Imaging).
contrast Echocardiography
An important technical innovation is the introduction 
of intravenous sonographic contrast. This is a non-iodine-
containing emulsion of inert gas microbubbles encapsulated 
in an albumin or lipid shell, which oscillate when exposed to 
ultrasound, producing a strong acoustic backscattered signal. 
Injection of this contrast, which is very safe, highly enhances 
the contrast between the blood pool and the myocardium. This 
vastly improves the diagnostic quality, especially in patients 
with poor ultrasound penetration. An interesting offshoot 
of this technology is the use of the rate of replenishment of 
myocardium with contrast to assess myocardial perfusion in the 
assessment of suspected ischaemic heart disease. In the future, 
specially designed microbubbles with specific ligands attached to 
their shells may be used to image diseased tissue or even deliver 
drugs and genetic material to the targeted tissue.
The main role of contrast echocardiography is to diagnose 
the nature of structures within the heart which are difficult to 
visualise on non-enhanced scanning. Common examples are 
intramural thrombi, benign trabeculations and the prominent 
trabeculations of non-compaction cardiomyopathy, intracardiac 
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Figure 1: Contrast enhanced 
echocardiogram showing a tumour 
(arrow) in the right ventricular apex. 
The presence of speckles of contrast 
within the tumour confirms the 
presence of vascularity and effectively 
excludes an intracardiac thrombus.
Figure 2: The effect of intravenous contrast on improving 
endocardial delineation in the left ventricle in a patient with 
poor image definition.
Figure 3: A dobutamine stress echo image with 
sonographic contrast enhancement showing short axis cuts 
of the left ventricle in quadrant format, acquired during 
baseline (top left), low dose (top right), intermediate dose 
(bottom left) and peak dose dobutamine infusion (bottom 
right). The quadrants on the left (D) are diastolic images, 
while those on the right (S) are systolic images. Note the 
systolic thinning of the inferior and inferolateral walls (red 
arrow) at peak dobutamine dose on the right, suggestive of 
ischaemia in the right coronary artery territory, becoming 
manifest at peak pharmacological stress.
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tumours (figure 1), the localised myocardial thickening of 
hypertrophic cardiomyopathy and visualisation of the right 
ventricle in suspected arrhythmogenic right ventricular 
cardiomyopathy.  Contrast is often used simply to enhance the 
endocardial lining to facilitate quantification of left ventricular 
function (figure 2). Finally, the use of intravenous contrast has 
immensely increased the feasibility and diagnostic potential of 
stress echocardiography.
strEss Echocardiography
The main use of this technology is in the diagnosis of 
cardiac ischaemia in patients with chest pain. This modality 
is based on assessing the contractile response to inotropic 
drugs (dobutamine), vasodilators (dipyridamole or adenosine) 
or exercise stress (bicycle or treadmill). Typically, ischaemic 
segments manifest decreased and delayed systolic thickening 
at high levels of inotropic stress (figure 3). Such a response 
has been shown to be highly accurate in detecting significant 
coronary stenosis and providing prognostic information on 
the likelihood of cardiac events, with a performance similar 
to other functional imaging modalities such as nuclear 
imaging. Whereas the technology has been previously limited 
by technical problems in visualising all segments of the heart 
muscle, the use of contrast has eliminated this problem in 
more than 95% of heart segments, and significantly increased 
accuracy in the detection of coronary stenosis. Thus, this cheap, 
versatile and safe modality is considered to be one of the first 
line investigations for the diagnosis of suspected ischaemia in 
patients with moderate likelihood of coronary artery disease. 
Finally, routine indications for stress echocardiography have, 
over the years, extended beyond the diagnosis of coronary artery 
disease to include assessment of myocardial viability, valve 
disease, hypertrophic cardiomyopathy and diastolic function.
3d Echocardiography
Probably the most impressive development in image 
acquisition and processing is 3D echocardiography. Whereas 
previously an experienced cardiologist had to mentally 
reconstruct a 3D appreciation of a structure from a series of 
strategically acquired 2D images, modern transducers are 
capable of acquiring a 3D pyramidal-shaped block of data, 
allowing real-time visualisation of cardiac structures and their 
complex spatial relation with neighbouring structures.  The 
high resolution images obtained by transoesophageal imaging 
(by virtue of the proximity of the probe to the structures being 
interrogated, allowing the use of a higher frequency probe) 
lend themselves nicely to 3D reconstruction, generating images 
which have revolutionised the approach towards heart disease. 
This has proved indispensable in assessing valvular heart disease 
(figure 4), measuring ventricular volumes (figure 5), and guiding 
percutaneous cardiac procedures. Providing a 3D view of a 
complex three-dimensional structure such as the regurgitant 
mitral valve facilitates communication with the surgeon (the 
imager can literally see what the surgeon sees) and facilitates 
the appreciation of disease by less experienced operators (figure 
4). Complex 3D structures such as the mitral valve annulus can 
be quantified with commercially available software, leading to 
highly informative models (figure 6). There is no doubt that such 
models prove indispensable for understanding the mechanism 
of disease and guiding surgical intervention.
conclusion
Echocardiography is a well-established technique, with 
the main advantages being its low cost, portability and lack of 
ionising radiation. However, ultrasound physics places some 
inevitable constraints on the technology. Some patients have 
poor image quality, and unusual cardiac anatomy can prove 
difficult to quantify, regardless of the operator expertise. Some 
structures are beyond ultrasonic interrogation, either because 
they lie behind bone (like the right ventricle in some patients), 
behind air-containing organs (such as the ascending and 
descending aorta) or simply because they are too far away from 
the transducer (as in obese patients). The use of intravenous 
contrast has gone a long way in improving image quality in 
challenging patients, but there will always be physical limits to 
ultrasound propagation in tissue, no matter how advanced the 
computing power at hand. This is where tomographic imaging, 
the topic of the next review, enters the scene.  
Figure 6: 3D model of the mitral valve annulus and leaflets showing prolapse 
of the middle scallop of the posterior mitral valve leaflet causing severe 
regurgitation. The model is accompanied by various automatically-derived 
parameters quantifying the shape of the mitral valve complex (right of 
image). P - posterior aspect; A - anterior aspect; PM - posteromedial aspect; 
AL - anterolateral aspect; Ao - aortic valve.
Figure 4: Examples of 3D images acquired during transoesophageal echocardiography. A. Dehiscence 
of a metallic valve prosthesis in mitral position (arrow) causing severe paraprosthetic leak; B. Atrial 
view of mitral valve endocarditis showing two vegetations (arrows) on the leaflets; C. Oblique atrial 
view of mitral valve showing a ruptured chord (arrow) inside left atrium.
Figure 5: Multiparametric information obtained from 
a single 3D acquisition of the left ventricle, including a 
3D colour-coded cast of regional contraction patterns 
(top left), volumetric data (top right), a “bull’s eye” 
view of regional contraction (bottom left), and regional 
volume-time curves (bottom right). EF - Ejection 
Fraction; EDV - End-diastolic  volume; ESV - End-
systolic volume; SV - Stroke volume.
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